Ajanta Pharma share news and announcements
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Last close ₹3,283.90up ₹13.30 (0.41%)BSE ₹3,281.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,270.60.
52-week range of traded prices to 23 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹41,035 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 36.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 5 May 2026
- 9.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 27.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 5 May 2026
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,54,84762.5% delivered
Ajanta Pharma record dates, bonuses and splits
30 filed, newest first.
Jul 2026
30 Jul · Corporate action
Nov 2025
3 Nov · Corporate action
Oct 2024
28 Oct · Corporate action
23 Oct · Corporate action
May 2024
2 May · Corporate action
Jan 2024
31 Jan · Corporate action
25 Jan · Corporate action
Jul 2023
24 Jul · Corporate action
Mar 2023
10 Mar · Corporate action
Oct 2022
31 Oct · Corporate action
Jun 2022
13 Jun · Corporate action
May 2022
Dec 2021
28 Dec · Corporate action
Oct 2021
29 Oct · Corporate action
Nov 2020
3 Nov · Corporate action
Jun 2020
Oct 2019
May 2019
Jan 2019
Oct 2018
Mar 2017
Oct 2016
Mar 2016
Mar 2015
Jan 2015
28 Jan · Corporate action
At the Board meeting held on January 28,2015, the Board has: Approved sub-division of nominal value of equity shares of the Company from Rs. 5/- each to nominal value of Rs. 2/- each and consequential amendment to the Memorandum of Association and Articles of Association, subject to approval of Members of the Company to be taken by postal ballot.
Sep 2013
5 Sep · Corporate action
Company has fixed Record Date as September 18, 2013 for the purpose of declaration and approval of issue of Bonus Equity Shares in the ratio of One (1) new fully paid-up Equity Shares of Rs.5/- each for every Two (2) fully paid-up shares held.
Jul 2013
29 Jul · Corporate action
Board of Directors of the Company at its meeting held on July 29, 2013 have recommended issue of bonus shares to existing shareholders in the ratio of 1:2 subject to the receipt of approval of the equity shareholders by way of Postal Ballot.
Jul 2012
19 Jul · Corporate action
Shareholders of the Company at their Annual General Meeting had approved splitting of shares from a face-value of Rs. 10/- each into two shares of a face-value of Rs. 5/- each. The Board of Directors has fixed the record date for the said corporate action as August 10, 2012.
Jul 2007
27 Jul · Corporate action
Company shall close its Equity Share Transfer Books for a period from September 21, 2007 to September 28, 2007 (both days inclusive). The said Book Closure is for declaration of dividend. The Board has recommended dividend @ 20% to be paid to the shareholders if the same is approved by the shareholders in the Annual General Meeting to be held on September 28, 2007.